| Product Code: ETC7655156 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Lumasiran Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Lumasiran Market - Industry Life Cycle |
3.4 Israel Lumasiran Market - Porter's Five Forces |
3.5 Israel Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Israel Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Israel Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in Israel |
4.2.2 Rising awareness about RNA interference (RNAi) therapy |
4.2.3 Strong government support for research and development in the healthcare sector |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new pharmaceutical products |
4.3.2 High costs associated with developing and marketing RNAi therapies |
5 Israel Lumasiran Market Trends |
6 Israel Lumasiran Market, By Types |
6.1 Israel Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Israel Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Israel Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Israel Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Israel Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Israel Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Israel Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Israel Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Israel Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Israel Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Israel Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Israel Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Israel Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Israel Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Israel Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Israel Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Lumasiran Market Import-Export Trade Statistics |
7.1 Israel Lumasiran Market Export to Major Countries |
7.2 Israel Lumasiran Market Imports from Major Countries |
8 Israel Lumasiran Market Key Performance Indicators |
8.1 Number of patients receiving lumasiran treatment in Israel |
8.2 Research and development investment in RNAi therapies by pharmaceutical companies |
8.3 Number of clinical trials for RNAi therapies conducted in Israel |
9 Israel Lumasiran Market - Opportunity Assessment |
9.1 Israel Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Israel Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Israel Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Lumasiran Market - Competitive Landscape |
10.1 Israel Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Israel Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here